Brief: NLS Pharmaceutics Announces Pricing Of $20.0 Mln Initial Public Offering
29/01/2021 24:38
Jan 29 (Reuters) - NLS Pharmaceutics AG NLSP.O :
* NLS PHARMACEUTICS LTD. ANNOUNCES PRICING OF $20.0 MILLION
INITIAL PUBLIC OFFERING
* PRICING OF ITS INITIAL PUBLIC OFFERING OF 4,819,277 UNITS
AT A
PRICE OF $4.15 PER UNIT
Source text for Eikon: ID:nPn4b7Qzza
Further company coverage: NLSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing